New study flags smaller-than-expected muscle impact from GLP-1 medications

1 min read
Source: The Washington Post
New study flags smaller-than-expected muscle impact from GLP-1 medications
Photo: The Washington Post
TL;DR Summary

A new study suggests GLP-1 weight-loss drugs (such as Ozempic and Wegovy) may not cause as much muscle loss as previously feared, while reinforcing the importance of regular exercise to preserve muscle when taking these medications.

Share this article

Reading Insights

Total Reads

0

Unique Readers

19

Time Saved

21 min

vs 22 min read

Condensed

99%

4,28936 words

Want the full story? Read the original article

Read on The Washington Post